tradingkey.logo
搜尋

Vivos Therapeutics Inc

VVOS
添加自選
0.410USD
+0.004+1.03%
收盤 07-31 16:00美東報價延遲15分鐘
3.81M總市值
虧損本益比TTM

關於 Vivos Therapeutics Inc 公司

Vivos Therapeutics, Inc. is a medical technology company focused on developing and commercializing diagnostic and treatment methods that promote sleep wellness and health for patients suffering from breathing and sleep issues such as obstructive sleep apnea (OSA) and snoring in adults. The Company's Complete Airway Repositioning and/or Expansion (CARE) devices are the oral appliances cleared by the United States Food and Drug Administration (FDA) for adult patients diagnosed with all severity levels of OSA (including severe OSA) and moderate-to-severe OSA in children ages 6 to 17 within the FDA cleared usage for such devices. The Company's products and services include Vivos CARE oral appliance therapy, Vivos oral appliances and therapies outside of CARE system, Vivos AireO2, Adjunctive Treatment, Treatment Navigator, Vivos Billing Intelligence Service (BIS) and Vivos Airway Intelligence Service, and others. The Company has sleep testing centers and associated medical sleep practice.

Vivos Therapeutics Inc簡介

公司代碼VVOS
公司名稱Vivos Therapeutics Inc
上市日期Dec 11, 2020
CEOHuntsman (R. Kirk)
員工數量109
證券類型Ordinary Share
年結日Dec 11
公司地址7921 Southpark Plaza,
城市LITTLETON
上市交易所NASDAQ OMX - NASDAQ BASIC
國家United States of America
郵編80120
電話18669084867
網址https://vivos.com/
公司代碼VVOS
上市日期Dec 11, 2020
CEOHuntsman (R. Kirk)

Vivos Therapeutics Inc公司高管

名稱
名稱/職務
職務
持股
持股變動
Mr. Bradford K. (Brad) Amman
Mr. Bradford K. (Brad) Amman
Chief Financial Officer
Chief Financial Officer
80.00
--
Mr. R. Kirk Huntsman
Mr. R. Kirk Huntsman
Chairman of the Board, Chief Executive Officer, Co-Founder
Chairman of the Board, Chief Executive Officer, Co-Founder
--
--
Dr. Ralph E. Green, DDS
Dr. Ralph E. Green, DDS
Independent Director
Independent Director
--
--
Ms. Anja B. Krammer
Ms. Anja B. Krammer
Independent Director
Independent Director
--
--
Mr. Mark F. Lindsay
Mr. Mark F. Lindsay
Independent Director
Independent Director
--
--
Mr. Leonard J. (Lenny) Sokolow, CPA
Mr. Leonard J. (Lenny) Sokolow, CPA
Independent Director
Independent Director
--
--
Dr. Matthew Thompson, M.D.
Dr. Matthew Thompson, M.D.
Independent Director
Independent Director
--
--
名稱
名稱/職務
職務
持股
持股變動
Mr. Bradford K. (Brad) Amman
Mr. Bradford K. (Brad) Amman
Chief Financial Officer
Chief Financial Officer
80.00
--
Mr. R. Kirk Huntsman
Mr. R. Kirk Huntsman
Chairman of the Board, Chief Executive Officer, Co-Founder
Chairman of the Board, Chief Executive Officer, Co-Founder
--
--
Dr. Ralph E. Green, DDS
Dr. Ralph E. Green, DDS
Independent Director
Independent Director
--
--
Ms. Anja B. Krammer
Ms. Anja B. Krammer
Independent Director
Independent Director
--
--
Mr. Mark F. Lindsay
Mr. Mark F. Lindsay
Independent Director
Independent Director
--
--
Mr. Leonard J. (Lenny) Sokolow, CPA
Mr. Leonard J. (Lenny) Sokolow, CPA
Independent Director
Independent Director
--
--

常見問題

Vivos Therapeutics Inc的前五大股東是誰?

Vivos Therapeutics Inc的前五大股東如下:Mr. Bradford K. (Brad) Amman

有多少機構持有Vivos Therapeutics Inc(VVOS)的股份?

截至2026Q1,共有50家機構持有Vivos Therapeutics Inc的股份,合計持有的股份價值約為1.10M,占公司總股份的8.12% 。與2025Q4相比,機構持股有所增加,增幅為-71775.00。

哪個業務部門對Vivos Therapeutics Inc的收入貢獻最大?

在2026Q1,Sleep testing services業務部門對Vivos Therapeutics Inc的收入貢獻最大,創收2.56M,占總收入的37.74% 。
tradingkey.logo
風險提示:我們的網站和行動應用程式僅提供關於某些投資產品的一般資訊。Finsights 不提供財務建議或對任何投資產品的推薦,且提供此類資訊不應被解釋為 Finsights 提供財務建議或推薦。
投資產品存在重大投資風險,包括可能損失投資的本金,且可能並不適合所有人。投資產品的過去表現並不代表其未來表現。
Finsights 可能允許第三方廣告商或關聯公司在我們的網站或行動應用程式的任何部分放置或投放廣告,並可能根據您與廣告的互動情況獲得報酬。
© 版權所有: FINSIGHTS MEDIA PTE. LTD. 版權所有